BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
11/14/2022 - Genexa Appeals NAD Recommendation to Discontinue or Modify Pediatrician Preference and Ingredient Claims for OTC Kids’ Pain & Fever Medicine
New York, NY – Nov. 14, 2022 – The National Advertising Division (NAD) recommended that Genexa Inc. discontinue certain pediatrician preference claims and ingredient claims for its over the counter (OTC) Kids’ Pain & Fever medicine. Genexa will appeal NAD’s decision. The challenged claims appeared on the advertiser’s website, in social media posts, on physical point-of-sale displays, and in digital video advertising.
-
11/08/2022 - National Advertising Division Recommends P&G Discontinue or Modify Comparative Advertising Commercials for Puffs Ultra Soft Tissues vs. Kleenex
New York, NY – November 8, 2022 – Acting on a challenge brought by Kimberly-Clark Corporation, the National Advertising Division (NAD) recommended that The Procter & Gamble Company (P&G) discontinue two commercials for Puffs Ultra Soft Tissues or modify them to avoid conveying a misleading message about the softness, comfort, or safety of Kleenex tissues and that Puff’s tissues have visible quilt-like puffing.
-
11/07/2022 - National Advertising Division Recommends Comcast Modify or Discontinue Xfinity Mobile vs. T-Mobile Comparative Savings Claims
New York, NY – November 7, 2022 – The National Advertising Division (NAD) analyzed comparative savings claims made by Comcast Cable about its Xfinity Mobile Wireless service plan. NAD recommended that Comcast either discontinue a claim that Xfinity Mobile is 30% less than T-Mobile or modify the advertising to clearly and conspicuously disclose the T-Mobile plan that is the basis of comparison and the material differences between the plans.
-
11/02/2022 - National Advertising Review Board Finds Sanofi’s “#1 Doctor Recommended Ingredient” Claims for Zantac 360° Unsubstantiated
New York, NY – November 2, 2022 – A panel of the National Advertising Review Board (NARB), the appellate advertising law body of BBB National Programs, recommended that Sanofi Consumer Healthcare not use claims that Zantac 360° contains, or that famotidine is, “the #1 Doctor Recommended ingredient” or “the #1 Doctor Recommended ingredient among H2 Blockers.”
-
11/02/2022 - National Advertising Division Recommends Accredited Debt Relief Discontinue Quantified Performance Claims About Debt Relief and the Format of Its Website
New York, NY – November 2, 2022 – The National Advertising Division (NAD) recommended Accredited Debt Relief discontinue claims that convey strong unqualified messages regarding the typical results experienced by users of the Accredited Debt relief program. NAD also recommended that S3 Marketing discontinue the format of its rankings website.
-
11/01/2022 - CARU Finds Gameloft’s Disney Getaway Blast App in Violation of COPPA and CARU’s Advertising and Privacy Guidelines; Gameloft Agrees to Corrective Actions
McLean, VA – November 1, 2022 – The Children’s Advertising Review Unit (CARU) has found Gameloft S.A. in violation of the Children’s Online Privacy Protection Act (COPPA) and CARU’s Self-Regulatory Guidelines for Advertising and for Children’s Online Privacy Protection. Upon receipt of CARU’s inquiry, Gameloft proactively implemented changes to address CARU’s concerns regarding its advertising and privacy practices and continues to take other corrective actions to address the remaining violations.
-
10/26/2022 - National Advertising Division Finds “Gig Speeds Everywhere” Claim for Cox Gigablast Internet Supported; Recommends Others be Modified or Discontinued
New York, NY – October 26, 2022 – Acting on a challenge by AT&T, the National Advertising Division (NAD) determined that Cox Communications provided a reasonable basis for the express claim that Cox can deliver “gig speeds everywhere” and the implied claim that Cox can provide gig speeds to all of its customers and AT&T cannot provide gig speeds (or faster) to all of its customers. NAD recommended Cox modify other claims.
-
10/25/2022 - Direct Selling Self-Regulatory Council Recommends Visi Discontinue Certain Health-Related Product Performance Claims
McLean, VA – October 25, 2022 – The Direct Selling Self-Regulatory Council (DSSRC) of BBB National Programs recommended that certain health-related product performance claims made by Visi and its salesforce members be discontinued. The inquiry was commenced by DSSRC through its ongoing independent monitoring of advertising and marketing claims in the direct selling industry.
-
10/20/2022 - Direct Selling Self-Regulatory Council Recommends B-Epic Discontinue Certain Earnings and Product Performance Claims
McLean, VA – October 20, 2022 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that certain product performance and earnings claims made by B-Epic Worldwide, LLC and its salesforce be discontinued. B-Epic is a direct-selling company that markets health, detox, and fitness products. -
10/20/2022 - NARB Finds Glee Gum’s “Plant-Based,” “Made with Chicle,” “Natural,” Claims Supported; Recommends Discontinuance of “Plastic Free” Claims
New York, NY – October 20, 2022 – A panel of the National Advertising Review Board (NARB), the appellate advertising decision body of BBB National Programs, has determined that Mazee, LLC has reasonable support for claims that its Glee Gum is “plant-based,” “made with chicle,” and “natural.” However, the NARB Panel recommended that the advertiser discontinue claims that Glee Gum is “plastic-free.”